FIASP PENFILL
INSULINE ASPARTE
Active substance
INSULINE ASPARTE
Laboratory
LAPROPHAN
What is this medicine?
FIASP PENFILL: This substance is used in diabetes management. It acts on blood glucose through a mechanism that depends on the active ingredient.
Verified summary
INSULINE ASPARTE, SOLUTION INJECTABLE EN CARTOUCHE, 100 U / ML, BOITE DE 5 CARTOUCHES DE 3 ML DE SOLUTION
Common uses
Common uses: type 2 diabetes or insulin needs, metabolic follow-up, and blood-glucose control according to patient profile. General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Diabetology - antidiabetic
Laboratory
LAPROPHAN
Strength
100 U / ML
Form
SOLUTION INJECTABLE EN CARTOUCHE
Presentation
BOITE DE 5 CARTOUCHES DE 3 ML DE SOLUTION
Commercial status
Non commercialisé / Sans Prix
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: Not available in the verified source
Medicines with the same active substance
NOVORAPID PENFILL 100 U / ML
100 U / ML · Boîte de 5 cartouches de 3 ml
497,00 MAD
NOVOMIX 30 FLEXPEN 100 U / ML
100 U / ML · Boîte de 5 stylos pré/remplis de 3 ml
559,00 MAD
FIASP
100 U / ML · BOITE D’UN FLACON DE 10 ML DE SOLUTION
Not available in the verified source
FIASP FLEXTOUCH
100 U / ML · BOITE DE 1 STYLO DE 3 ML DE SOLUTION
Not available in the verified source
FIASP FLEXTOUCH
100 U / ML · BOITE DE 5 STYLOS DE 3 ML DE SOLUTION
Not available in the verified source